Page last updated: 2024-08-24

2,3-trimethylene-4-quinazolone and 3-deoxyvasicine

2,3-trimethylene-4-quinazolone has been researched along with 3-deoxyvasicine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Emami, S; Haghighijoo, Z; Moosavi, F; Zamani, L1

Reviews

1 review(s) available for 2,3-trimethylene-4-quinazolone and 3-deoxyvasicine

ArticleYear
Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Enzyme Inhibitors; Humans; Monoamine Oxidase; Neuroprotective Agents; Phosphoric Diester Hydrolases; Quinazolines; tau Proteins

2022